Percutaneous microwave ablation and transcatheter arterial chemoembolization for serum tumor markers and prognostics of middle-late primary hepatic carcinoma
Zhi-Peng Lin, Da-Bei Huang, Xu-Gong Zou, Yuan Chen, Xiao-Qun Li, Jian Zhang · 2023
Read Percutaneous microwave ablation and transcatheter arterial chemoembolization for serum tumor markers and prognostics of middle-late primary hepatic carcinoma by Zhi-Peng Lin, Da-Bei Huang, Xu-Gong Zou, Yuan Chen, Xiao-Qun Li, Jian Zhang (2023) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-10784823.txt.
Description
Zhi-Peng Lin and co-authors compare two treatments for mid to late liver cancer, in a 2023 study. The standard path threads a tube to the tumor and blocks its blood supply while dosing it with drugs. Heat ablation through the skin can kill more tumor cells, and the pair may beat either alone.
One hundred fifty patients at one hospital split into a standard group and a combined group. The combined group had more full and partial responses. Blood tumor markers fell further in that group after four weeks. The team also tracked one year survival and the traits that shaped outlook. Their results back the combined path for this hard stage of disease.
Catalog record
| CREATOR | Zhi-Peng Lin, Da-Bei Huang, Xu-Gong Zou, Yuan Chen, Xiao-Qun Li, Jian Zhang |
|---|---|
| YEAR | 2023 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 27 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |